⌘K

Login Start Free

Home/Filings/4/0001209191-15-005152

4//SEC Filing

Adamas Pharmaceuticals Inc 4

Accession 0001209191-15-005152

CIK 0001328143operating

View on SEC.gov Company Profile

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 5:01 PM ET

Size

4.7 KB

Accession

0001209191-15-005152

Insider Transaction Report

Form 4

Period: 2015-01-15

Adamas Pharmaceuticals IncADMS

BOOTH RICHARD H

Director

Transactions

Sale
Common Stock
2015-01-15$17.43/sh−1,000$17,430→ 50,778 total

Footnotes (1)

[F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001328143

Filing Metadata

Form type: 4
Filed: Jan 19, 7:00 PM ET
Accepted: Jan 20, 5:01 PM ET
Size: 4.7 KB

View on SEC.gov